Publications by authors named "Dengdi Hu"

Claim this Profile
B
Biological differences between normal and cancer-associated fibroblasts in breast cancer.
Dengdi Hu, Wenying Zhuo, Peirong Gong, Feiyang Ji, Xun Zhang

Heliyon· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated fibroblasts in breast cancer: Challenges and opportunities.
Dengdi Hu, Zhaoqing Li, Bin Zheng, Xixi Lin, Yuehong Pan, Wenying Zhuo, Yujie Hu, Jichun Zhou

Cancer Commun (Lond)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Zhaoqing Li, Cong Chen, Lini Chen, Dengdi Hu, Xiqian Yang, Wenying Zhuo, Qinchuan Wang, Shuduo Xie, Jichun Zhou

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer.
Yongxia Chen, Yunlu Jia, Misha Mao, Yifeng Gu, Chenpu Xu, Wenxian Hu, Dengdi Hu, Jichun Zhou

J Cell Mol Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Zhaoqing Li, Cong Chen, Lini Chen, Dengdi Hu, Xiqian Yang, Wenying Zhuo, Qinchuan Wang, Shuduo Xie, Jichun Zhou

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of tamoxifen sensitivity by the PLAC8/MAPK pathway axis is antagonized by curcumin-induced protein stability change.
Misha Mao, Dengdi Hu, Jingjing Yang, Yongxia Chen, Xun Zhang, Jichun Zhou

J Mol Med (Berl)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient.
Zhaoqing Li, Wenying Zhuo, Lini Chen, Xun Zhang, Cong Chen, Dengdi Hu, Qinchuan Wang, Shuduo Xie, Jichun Zhou

Front Cell Dev Biol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retracted] LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
Wenying Zhuo, Dengdi Hu, Xihua Chen, Tian Zhang

Mol Med Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival.
Jianfeng Tian, Dengdi Hu

Clin Res Hepatol Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ferroptosis in breast cancer.
Zhaoqing Li, Lini Chen, Cong Chen, Yulu Zhou, Dengdi Hu, Wenying Zhuo, Jichun Zhou

Biomark Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
Wenying Zhuo, Dengdi Hu, Xihua Chen, Tian Zhang

Mol Med Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.
Dengdi Hu, Dan Shen, Min Zhang, Nengmeng Jiang, Feng Sun

Am J Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis